Philip J. Ryan

2.0k total citations
35 papers, 1.4k citations indexed

About

Philip J. Ryan is a scholar working on Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Endocrine and Autonomic Systems. According to data from OpenAlex, Philip J. Ryan has authored 35 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Philip J. Ryan's work include Pregnancy-related medical research (9 papers), Blood Pressure and Hypertension Studies (6 papers) and Neuroscience of respiration and sleep (4 papers). Philip J. Ryan is often cited by papers focused on Pregnancy-related medical research (9 papers), Blood Pressure and Hypertension Studies (6 papers) and Neuroscience of respiration and sleep (4 papers). Philip J. Ryan collaborates with scholars based in Australia, United States and United Kingdom. Philip J. Ryan's co-authors include Amy Salter, LN Yelland, Andrew L. Gundlach, Sherie Ma, Mohammed Akhter Hossain, John D. Wade, Nigel Stocks, Ross A. D. Bathgate, Andrew J. Lawrence and Francisco E. Olucha‐Bordonau and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Neuroscience.

In The Last Decade

Philip J. Ryan

35 papers receiving 1.4k citations

Peers

Countries citing papers authored by Philip J. Ryan

Since Specialization

Citations

This map shows the geographic impact of Philip J. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip J. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip J. Ryan more than expected).

Fields of papers citing papers by Philip J. Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip J. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip J. Ryan. The network helps show where Philip J. Ryan may publish in the future.

Co-authorship network of co-authors of Philip J. Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Philip J. Ryan. A scholar is included among the top collaborators of Philip J. Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip J. Ryan. Philip J. Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oxytocin-receptor-expressing neurons in the lateral parabrachial nucleus activate widespread brain regions predominantly involved in fluid satiation 2024 ·Journal of Chemical Neuroanatomy ·(unknown), (unknown), Andrew J. Lawrence, Philip J. Ryan	2
2	A phase I trial of SON-1010, a tumor-targeted, interleukin-12-linked, albumin-binding cytokine, shows favorable pharmacokinetics, pharmacodynamics, and safety in healthy volunteers 2024 ·Frontiers in Immunology ·Richard T. Kenney, (unknown), (unknown), (unknown), (unknown), (unknown), Sant P. Chawla, Thomas M. Polasek, Jason D. Lickliter, Philip J. Ryan	1
3	Phase 1 Healthy Volunteer Study of AL01211, an Oral, Non‐brain Penetrant Glucosylceramide Synthase Inhibitor, to Treat Fabry Disease and Type 1 Gaucher Disease 2024 ·Clinical Pharmacology in Drug Development ·M. A. Babcock, (unknown), (unknown), Li Li, Bing Wang, Pedro E. Huertas, Philip J. Ryan, Yuqiao Shen, Marvin R. Garovoy	4
4	Feeding signals inhibit fluid‐satiation signals in the mouse lateral parabrachial nucleus to increase intake of highly palatable, caloric solutions 2023 ·Journal of Neurochemistry ·(unknown), (unknown), Warren Davis, (unknown), Stuart J. McDougall, Andrew J. Lawrence, Philip J. Ryan	4
5	Oxytocin-receptor-expressing neurons in the parabrachial nucleus regulate fluid intake 2017 ·Nature Neuroscience ·Philip J. Ryan, (unknown), Carlos Campos, V. A. Derkach, Richard D. Palmiter	88
6	Relaxin-3 mRNA levels in nucleus incertus correlate with alcohol and sucrose intake in rats 2014 ·Drug and Alcohol Dependence ·Philip J. Ryan, Elena Krstew, Mohsin Sarwar, Andrew L. Gundlach, Andrew J. Lawrence	26
7	Central relaxin-3 receptor (RXFP3) activation decreases anxiety- and depressive-like behaviours in the rat 2013 ·Behavioural Brain Research ·Philip J. Ryan, (unknown), Fazel Shabanpoor, Mohammed Akhter Hossain, John D. Wade, Andrew J. Lawrence, Andrew L. Gundlach	69
8	Chemical synthesis and orexigenic activity of rat/mouse relaxin-3 2013 ·Amino Acids ·Mohammed Akhter Hossain, Craig M. Smith, Philip J. Ryan, (unknown), Ross A. D. Bathgate, Andrew L. Gundlach, John D. Wade	14
9	Minimization of Human Relaxin-3 Leading to High-Affinity Analogues with Increased Selectivity for Relaxin-Family Peptide 3 Receptor (RXFP3) over RXFP1 2012 ·Journal of Medicinal Chemistry ·Fazel Shabanpoor, Mohammed Akhter Hossain, Philip J. Ryan, Alessia Belgi, Sharon Layfield, Martina Kočan, Suode Zhang, Chrishan S. Samuel, Andrew L. Gundlach, Ross A. D. Bathgate, Frances Separovic, John D. Wade	75
10	Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides 2012 ·Behavioural Pharmacology ·Despina E. Ganella, Philip J. Ryan, Ross A. D. Bathgate, Andrew L. Gundlach	37
11	Performance of the Modified Poisson Regression Approach for Estimating Relative Risks From Clustered Prospective Data 2011 ·American Journal of Epidemiology ·LN Yelland, Amy Salter, Philip J. Ryan	334
12	Relaxin-3 systems in the brain—The first 10 years 2011 ·Journal of Chemical Neuroanatomy ·Craig M. Smith, Philip J. Ryan, Ihaia T. Hosken, Sherie Ma, Andrew L. Gundlach	89
13	Nucleus incertus—An emerging modulatory role in arousal, stress and memory 2011 ·Neuroscience & Biobehavioral Reviews ·Philip J. Ryan, Sherie Ma, Francisco E. Olucha‐Bordonau, Andrew L. Gundlach	90
14	A Score for the Prediction of Cardiovascular Events in the Hypertensive Aged 2011 ·American Journal of Hypertension ·Mark Nelson, Emmae Ramsay, Philip J. Ryan, Kristyn Willson, Andrew Tonkin, L. M. H. Wing, Leon A. Simons, Christopher M. Reid	6
15	Second Australian National Blood Pressure Study (ANBP2) - Comparative outcome trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly: Principal results 2003 ·Clinical and Experimental Pharmacology and Physiology ·(unknown), (unknown), Philip J. Ryan, Lawrence J. Beilin, M. J. Brown, (unknown), C. I. Johnston, John J. McNeil, G. J. Macdonald, (unknown), (unknown), MJ West	6
16	`Reverse white-coat hypertension’ in older hypertensives 2002 ·Journal of Hypertension ·Lindon M.H. Wing, Mark Brown, Lawrence J. Beilin, Philip J. Ryan, Christopher M. Reid	91
17	Production of Colony-Stimulating Factors and IL-5 by Organs from Three Types of Mice with Inflammatory Disease Due to Loss of the Suppressor of Cytokine Signaling-1 2001 ·The Journal of Immunology ·Donald Metcalf, Warren S. Alexander, Philip J. Ryan, Sandra Mifsud, Ladina Di Rago	10
18	Short report. Variation in mortality rates in Australia: correlation with indigenous status, remoteness and socio-economic deprivation 2001 ·Journal of Public Health ·David Wilkinson, Philip J. Ryan, Janet E. Hiller	20
19	The multi-organ origin of interleukin-5 in the mouse 2001 ·Leukemia ·Philip J. Ryan, Tracy A. Willson, Alexander Ws, (unknown), Sandra Mifsud, D Metcalf	8
20	FEASIBILITY OF CONDUCTING CARDIOVASCULAR OUTCOME RESEARCH IN AUSTRALIAN GENERAL PRACTICE: RESULTS FROM THE ANBP2 PILOT STUDY 1997 ·Clinical and Experimental Pharmacology and Physiology ·(unknown), Meredith Nelson, (unknown), Philip J. Ryan, (unknown), Lawrence J. Beilin, (unknown), Garry Jennings, (unknown), John Marley, John J. McNeil, (unknown), John Shaw, (unknown), (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact